Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer †
Titel:
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer †
Auteur:
Gonzalez-Angulo, A.M. Akcakanat, A. Liu, S. Green, M.C. Murray, J.L. Chen, H. Palla, S.L. Koenig, K.B. Brewster, A.M. Valero, V. Ibrahim, N.K. Moulder-Thompson, S. Litton, J.K. Tarco, E. Moore, J. Flores, P. Crawford, D. Dryden, M.J. Symmans, W.F. Sahin, A. Giordano, S.H. Pusztai, L. Do, K.-A. Mills, G.B. Hortobagyi, G.N. Meric-Bernstam, F.